According to the Observer Network, the British pharmaceutical company AstraZeneca said on May 7, local time, that due to “excess available vaccines” since the COVID-19 pandemic, the company has begun to remove the COVID-19 vaccine globally. Reuters and Britain's “Daily Telegraph” mentioned that AstraZeneca recently acknowledged in court documents that its COVID-19 vaccine may cause rare side effects such as cerebral thrombosis.
据观察者网消息英国制药公司阿斯利康当地时间5月7日表示由于新冠疫情以来“可用疫苗过剩”该公司已开始在全球范围内下架新冠疫苗。路透社和英国《每日电讯报》提到阿斯利康公司日前在法庭文件中承认其新冠疫苗可能引起脑血栓等罕见副作用。
According to the Observer Network, the British pharmaceutical company AstraZeneca said on May 7, local time, that due to “excess available vaccines” since the COVID-19 pandemic, the company has begun to remove the COVID-19 vaccine globally. Reuters and Br
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.